Clin2
NCT07841314Possibly a fitNot yet recruiting

Unani formulation vs active control for plaque psoriasis

Chronic Plaque PsoriasisPlaque PsoriasisPsoriasisTaqashshur al Jild

Part of Skin clinical trials.

This study compares an Unani herbal formulation to an active control in treating people with plaque psoriasis. If you have mild to moderate plaque psoriasis, this trial might help you find a new natural treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
54 people
Ages
20 years to 60 years
Study type
Interventional

Who can take part

  • You are between 20 and 60 years old.
  • You have been diagnosed with chronic plaque psoriasis (either newly or by a doctor).
  • Your psoriasis severity is mild to moderate, with a PASI score between 3 and 20.
  • Your psoriasis lesions are on both sides of your body (symmetrical).
  • You are not taking medications that can make psoriasis worse, such as beta-blockers, calcium channel blockers, or lithium.
  • You are not pregnant or breastfeeding, and you don't have severe psoriasis (PASI > 20) or certain other skin conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07129382Recruiting· Phase 1/Phase 2
Study of CS32582 for moderate to severe plaque psoriasis

This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.

Beijing, Beijing Municipality
NCT07038720Recruiting· Phase 1
Testing an experimental oral tablet for moderate to severe psoriasis

This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.

Hangzhou, Zhejiang
NCT06672393Not yet recruiting· Phase 3
Study of a new pill for moderate to severe plaque psoriasis

This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.

Shanghai, Shanghai Municipality
NCT07158268Not yet recruiting· Phase 2
Oral medication for moderate to severe plaque psoriasis

This study tests an oral medication (HSK47388) as a treatment for moderate-to-severe plaque psoriasis, the most common type. It may help reduce symptoms like red, scaly patches and improve quality of life.

NCT07780929Recruiting
Study of XJH05 ointment for mild-to-moderate plaque psoriasis

This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.

Xi'an, Shaanxi
NCT06926582Not yet recruiting· Phase 2
New pill for mild-to-moderate plaque psoriasis

This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.

Shanghai, Shanghai Municipality

Hear when a new Plaque Psoriasis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.